153 related articles for article (PubMed ID: 35394038)
1. The impact of Loa loa microfilaraemia on research subject retention during a whole sporozoite malaria vaccine trial in Equatorial Guinea.
Manock SR; Nsue VU; Olotu A; Mpina M; Nyakarungu E; Raso J; Mtoro A; Ondo Mangue ME; Ntutumu Pasialo BE; Nguema R; Riyahi P; Schindler T; Daubenberger C; Church LWP; Billingsley PF; Richie TL; Abdulla S; Hoffman SL
Trans R Soc Trop Med Hyg; 2022 Aug; 116(8):745-749. PubMed ID: 35394038
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Plasmodium falciparum malaria infection in 6-month to 45-year-olds on selected areas of Bioko Island, Equatorial Guinea.
Nchama VUNN; Said AH; Mtoro A; Bidjimi GO; Owono MA; Maye ERM; Mangue MEO; Okomo GNN; Pasialo BEN; Ondo DM; Lopez MA; Mochomuemue FL; Obono MO; Besaha JCM; Chuquiyauri R; Jongo SA; Kamaka K; Kibondo UA; Athuman T; Falla CC; Eyono JNM; Smith JM; García GA; Raso J; Nyakarungu E; Mpina M; Schindler T; Daubenberger C; Lemiale L; Billingsley PF; Sim BKL; Richie TL; Church LWP; Olotu A; Tanner M; Hoffman SL; Abdulla S
Malar J; 2021 Jul; 20(1):322. PubMed ID: 34284778
[TBL] [Abstract][Full Text] [Related]
3. Characterising co-infections with Plasmodium spp., Mansonella perstans or Loa loa in asymptomatic children, adults and elderly people living on Bioko Island using nucleic acids extracted from malaria rapid diagnostic tests.
Yoboue CA; Hosch S; Donfack OT; Guirou EA; Nlavo BM; Ayekaba MO; Guerra C; Phiri WP; Garcia GA; Schindler T; Daubenberger CA
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0009798. PubMed ID: 35100277
[TBL] [Abstract][Full Text] [Related]
4. Loiasis in US Traveler Returning from Bioko Island, Equatorial Guinea, 2016.
Priest DH; Nutman TB
Emerg Infect Dis; 2017 Jan; 23(1):160-162. PubMed ID: 27983940
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of capillary and venous blood samples in the detection of Loa loa and Mansonella perstans microfilaraemia using light microscopy.
Mischlinger J; Manego RZ; Mombo-Ngoma G; Ekoka Mbassi D; Hackbarth N; Ekoka Mbassi FA; Davi SD; Kreuzmair R; Veletzky L; Hergeth J; Ndoumba WN; Pitzinger P; Groger M; Matsiegui PB; Adegnika AA; Agnandji ST; Lell B; Ramharter M
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009623. PubMed ID: 34398886
[TBL] [Abstract][Full Text] [Related]
6. The Development of Whole Sporozoite Vaccines for
Itsara LS; Zhou Y; Do J; Grieser AM; Vaughan AM; Ghosh AK
Front Immunol; 2018; 9():2748. PubMed ID: 30619241
[TBL] [Abstract][Full Text] [Related]
7. Exploring immunological mechanisms of the whole sporozoite vaccination against P. falciparum malaria.
Mo AX; Pesce J; Hall BF
Vaccine; 2015 Jun; 33(25):2851-7. PubMed ID: 25917675
[TBL] [Abstract][Full Text] [Related]
8. Temporal variability of Loa loa microfilaraemia.
Campillo JT; Hemilembolo MC; Louya F; Bikita P; Pion SDS; Boussinesq M; Missamou F; Chesnais CB
Parasit Vectors; 2023 Jan; 16(1):23. PubMed ID: 36691079
[TBL] [Abstract][Full Text] [Related]
9. Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines.
Richie TL; Billingsley PF; Sim BK; James ER; Chakravarty S; Epstein JE; Lyke KE; Mordmüller B; Alonso P; Duffy PE; Doumbo OK; Sauerwein RW; Tanner M; Abdulla S; Kremsner PG; Seder RA; Hoffman SL
Vaccine; 2015 Dec; 33(52):7452-61. PubMed ID: 26469720
[TBL] [Abstract][Full Text] [Related]
10. Molecular Surveillance of Artemisinin-Based Combination Therapies Resistance in Plasmodium falciparum Parasites from Bioko Island, Equatorial Guinea.
Liu Y; Liang X; Li J; Chen J; Huang H; Zheng Y; He J; Ehapo CS; Eyi UM; Yang P; Lin L; Chen W; Sun G; Liu X; Zha G; Wang J; Wang C; Wei H; Lin M
Microbiol Spectr; 2022 Jun; 10(3):e0041322. PubMed ID: 35670601
[TBL] [Abstract][Full Text] [Related]
11. Association between blood Loa loa microfilarial density and proteinuria levels in a rural area of the Republic of Congo (the MorLo project): a population-based cross-sectional study.
Campillo JT; Hemilembolo MC; Pion SDS; Lebredonchel E; Dupasquier V; Boullé C; Rancé LG; Boussinesq M; Missamou F; Chesnais CB
Lancet Microbe; 2023 Sep; 4(9):e704-e710. PubMed ID: 37480932
[TBL] [Abstract][Full Text] [Related]
12. [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
Ducorps M; Gardon-Wendel N; Ranque S; Ndong W; Boussinesq M; Gardon J; Schneider D; Chippaux JP
Bull Soc Pathol Exot; 1995; 88(3):105-12. PubMed ID: 8555762
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Monoclonal Gammopathy of Undetermined Significance is Associated with
Laskar DB; Rose M; Gupta R; Tanowitz HB; Haseeb MA
Am J Trop Med Hyg; 2018 Nov; 99(5):1206-1210. PubMed ID: 30203743
[TBL] [Abstract][Full Text] [Related]
14. Whole-Sporozoite Malaria Vaccine Candidate Shows Real-world Promise.
Larkin H
JAMA; 2023 Jan; 329(2):115. PubMed ID: 36625824
[No Abstract] [Full Text] [Related]
15. Molecular monitoring of the diversity of human pathogenic malaria species in blood donations on Bioko Island, Equatorial Guinea.
Schindler T; Robaina T; Sax J; Bieri JR; Mpina M; Gondwe L; Acuche L; Garcia G; Cortes C; Maas C; Daubenberger C
Malar J; 2019 Jan; 18(1):9. PubMed ID: 30646918
[TBL] [Abstract][Full Text] [Related]
16. Genetic diversity and natural selection on the thrombospondin-related adhesive protein (TRAP) gene of Plasmodium falciparum on Bioko Island, Equatorial Guinea and global comparative analysis.
Lin LY; Huang HY; Liang XY; Xie DD; Chen JT; Wei HG; Huang WY; Ehapo CS; Eyi UM; Li J; Wang JL; Zheng YZ; Zha GC; Wang YL; Chen WZ; Liu XZ; Mo HT; Chen XY; Lin M
Malar J; 2021 Mar; 20(1):124. PubMed ID: 33653360
[TBL] [Abstract][Full Text] [Related]
17. The Equatoguinean Malaria Vaccine Initiative: From the Launching of a Clinical Research Platform to Malaria Elimination Planning in Central West Africa.
Billingsley PF; Maas CD; Olotu A; Schwabe C; García GA; Rivas MR; Hergott DEB; Daubenberger C; Saverino E; Chaouch A; Embon O; Chemba M; Nyakarungu E; Hamad A; Cortes C; Schindler T; Mpina M; Mtoro A; Sim BKL; Richie TL; McGhee K; Tanner M; Obiang Lima GM; Abdulla S; Hoffman SL; Ayekaba MO
Am J Trop Med Hyg; 2020 Sep; 103(3):947-954. PubMed ID: 32458790
[TBL] [Abstract][Full Text] [Related]
18. Development of whole sporozoite malaria vaccines.
Hollingdale MR; Sedegah M
Expert Rev Vaccines; 2017 Jan; 16(1):45-54. PubMed ID: 27327875
[TBL] [Abstract][Full Text] [Related]
19. Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.
Pion SD; Nana-Djeunga H; Niamsi-Emalio Y; Chesnais CB; Deléglise H; Mackenzie C; Stolk W; Fletcher DA; Klion AD; Nutman TB; Boussinesq M; Kamgno J
Lancet Infect Dis; 2020 Jan; 20(1):102-109. PubMed ID: 31676244
[TBL] [Abstract][Full Text] [Related]
20. Geographical distribution and species identification of human filariasis and onchocerciasis in Bioko Island, Equatorial Guinea.
Ta TH; Moya L; Nguema J; Aparicio P; Miguel-Oteo M; Cenzual G; Canorea I; Lanza M; Benito A; Crainey JL; Rubio JM
Acta Trop; 2018 Apr; 180():12-17. PubMed ID: 29289559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
